Search

Halozyme Therapeutics Inc

Fechado

SetorSaúde

78.57 1.52

Visão Geral

Variação de preço das ações

24h

Atual

Mín

75.2

Máximo

77.72

Indicadores-chave

By Trading Economics

Rendimento

292M

150M

Vendas

-75M

377M

P/E

Médio do Setor

26.737

60.149

EPS

1.221

Margem de lucro

39.832

Funcionários

423

EBITDA

-62M

220M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+6.83% upside

Dividendos

By Acuity

Próximos Ganhos

4 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.4B

9B

Abertura anterior

77.05

Fecho anterior

78.57

Sentimento de Notícias

By Acuity

8%

92%

5 / 342 Ranking em Healthcare

Halozyme Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de jul. de 2026, 23:52 UTC

Social Media
News

Netflix Inc. shares fell in after-hours trading following Q2 results. Revenue of $12.56 billion missed expectations, and guidance for 2026 was narrowed lower.

16 de jul. de 2026, 23:46 UTC

News

Paychex declared a quarterly dividend of $1.19 per share, payable August 28, contributing to positive sentiment as shares rise in after-market trading.

16 de jul. de 2026, 23:46 UTC

ETF Constituents
News
Correlated Moves

Vanguard Growth ETF declines after-hours, impacted by Netflix's drop and broader Nasdaq 100 downturn amid rising inflation concerns and central bank comments.

16 de jul. de 2026, 23:41 UTC

News
Correlated Moves

Lam Research Corp shares are lower in after-market trading amid a sector-wide selloff following TSMC's capital expenditure announcement and bearish sentiment from options traders.

16 de jul. de 2026, 23:36 UTC

News

T-Mobile US Inc. experienced routine after-market trading with little change since Thursday's close, maintaining its focus on versatile mobile internet plans.

16 de jul. de 2026, 23:31 UTC

News
Correlated Moves

Micron Technology shares declined in after-market trading amid negative sentiment in the tech sector and concerns over rising capital costs from TSMC.

16 de jul. de 2026, 23:21 UTC

News
Social Media

PayPal Holdings Inc. shares are lower in after-market hours as its board deems a $53 billion takeover bid from Stripe inadequate amid broader market declines.

16 de jul. de 2026, 23:16 UTC

Correlated Moves
News

Intuit Inc shares are lower in after-market trading following a class action lawsuit alleging overstated revenue growth and competitive advantages. Concerns about layoffs persist.

16 de jul. de 2026, 23:16 UTC

News
Social Media

Alphabet Inc shares are higher in after-market trading, rebounding from earlier session lows. Concerns persist over delays in the rollout of its Gemini AI.

16 de jul. de 2026, 23:06 UTC

News

United Airlines Holdings Inc shares are lower in after-market hours, reflecting broader market declines amid concerns over major tech stocks and geopolitical risks.

16 de jul. de 2026, 23:02 UTC

News
Social Media

Intuitive Surgical shares fell in after-market trading despite strong earnings, as management cited U.S. market challenges and a Class II recall of surgical components.

16 de jul. de 2026, 23:01 UTC

News

Escalating military tensions in the Middle East are impacting the United States Oil Fund LP, which is trading lower during after-market hours.

16 de jul. de 2026, 23:01 UTC

News
ETF Constituents
Correlated Moves
Macro News

Vanguard Information Technology ETF declines after major indices drop, led by weakness in semiconductor stocks and a significant decline in Netflix shares.

16 de jul. de 2026, 23:01 UTC

News

Fiserv Inc. shares are lower in after-market trading amid operational challenges, including a 2% revenue decline and a significant drop in operating income.

16 de jul. de 2026, 20:07 UTC

News

Spot silver prices are higher today, despite earlier pulling back from a session high, amid escalating U.S.-Iran tensions and rising inflation concerns.

16 de jul. de 2026, 20:07 UTC

News
Correlated Moves

CHF/HKD is trading lower as initial jobless claims fall to a two-month low, indicating labor market strength amid rising geopolitical tensions.

16 de jul. de 2026, 20:06 UTC

News
Correlated Moves

Gold prices are lower as inflation risks rise amid the U.S.-Iran conflict. Earlier, gold peaked at $3,992.10 per ounce before declining.

16 de jul. de 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns, currently trading around $56.82 per ounce. Gold also fell sharply today.

16 de jul. de 2026, 20:06 UTC

Macro Event
Correlated Moves
News

Xcel Energy shares are higher, supported by analysts' positive ratings adjustments and a favorable move in the Electric Utilities sub-sector.

16 de jul. de 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower today, trading around $56.82 per ounce amid rising inflation concerns and expectations for Federal Reserve rate hikes.

16 de jul. de 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns. The metal is trading near $56.82 per ounce, reflecting broader weakness in precious metals.

16 de jul. de 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns, trading around $56.82 per ounce after a significant drop since Wednesday.

16 de jul. de 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower, trading around $56.82 per ounce amid rising U.S.-Iran tensions and inflation concerns. Gold also declined significantly today.

16 de jul. de 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower today, trading around $56.82 per ounce amid rising inflation concerns and expectations for Federal Reserve rate hikes.

16 de jul. de 2026, 20:06 UTC

Correlated Moves
News

GBP/HKD is trading lower amid the Bank of Korea's interest rate hike to 2.75%. The currency pair reached a session low following early gains.

16 de jul. de 2026, 20:03 UTC

Correlated Moves
News

Wedbush initiated coverage on Verisign with an Outperform rating. Shares are gaining today, reflecting positive sentiment after closing at $268.85.

16 de jul. de 2026, 20:03 UTC

News

O'Reilly Automotive advances amid speculation of a $10 billion acquisition of Genuine Parts' auto parts unit, with analysts citing potential benefits despite FTC review concerns.

16 de jul. de 2026, 20:03 UTC

Correlated Moves
Social Media
News

Qualcomm Inc shares are lower as the semiconductor sector faces pressure from Micron Technology's supply agreements and a notable decline in the Nasdaq 100 Index.

16 de jul. de 2026, 20:02 UTC

News

Align Technology Inc. reported first-quarter revenue of $1.00 billion, slightly above expectations, but shares are lower amid broader market unease and geopolitical tensions.

16 de jul. de 2026, 19:56 UTC

News
Social Media

Expedia Group shares rise after Wedbush initiated coverage with an Outperform rating and a price target of $334, indicating growth potential.

Comparação entre Pares

Variação de preço

Halozyme Therapeutics Inc Previsão

Preço-alvo

By TipRanks

6.83% parte superior

Previsão para 12 meses

Média 81 USD  6.83%

Máximo 96 USD

Mínimo 57 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Halozyme Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

3

Comprar

2

Manter

1

Vender

Sentimento

By Acuity

5 / 342 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
help-icon Live chat